loading
Precedente Chiudi:
$6.48
Aprire:
$6.5
Volume 24 ore:
902.88K
Relative Volume:
0.41
Capitalizzazione di mercato:
$2.34B
Reddito:
$9.47B
Utile/perdita netta:
$-178.00M
Rapporto P/E:
-13.15
EPS:
-0.48
Flusso di cassa netto:
$1.01B
1 W Prestazione:
-1.71%
1M Prestazione:
+2.10%
6M Prestazione:
-15.19%
1 anno Prestazione:
-14.50%
Intervallo 1D:
Value
$6.30
$6.5293
Intervallo di 1 settimana:
Value
$6.23
$6.5293
Portata 52W:
Value
$3.96
$9.85

Bausch Health Companies Inc Stock (BHC) Company Profile

Name
Nome
Bausch Health Companies Inc
Name
Telefono
514-744-6792
Name
Indirizzo
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Name
Dipendente
20,700
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
BHC's Discussions on Twitter

Confronta BHC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
BHC
Bausch Health Companies Inc
6.31 2.37B 9.47B -178.00M 1.01B -0.48
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
148.60 68.99B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.43 46.36B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.60 44.74B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.06 18.81B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
292.01 13.33B 2.99B 1.21B 1.13B 25.06

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-02 Downgrade Piper Sandler Neutral → Underweight
2024-07-10 Iniziato Raymond James Mkt Perform
2023-09-20 Aggiornamento Jefferies Hold → Buy
2023-06-16 Downgrade TD Cowen Outperform → Market Perform
2022-07-29 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-07-29 Downgrade Truist Buy → Hold
2022-07-28 Downgrade JP Morgan Overweight → Neutral
2022-06-13 Ripresa JP Morgan Overweight
2021-03-24 Downgrade BofA Securities Neutral → Underperform
2021-02-17 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2021-01-22 Downgrade Piper Sandler Overweight → Neutral
2020-09-17 Aggiornamento BofA Securities Underperform → Neutral
2020-08-24 Reiterato H.C. Wainwright Buy
2020-06-17 Reiterato H.C. Wainwright Buy
2020-04-24 Iniziato Citigroup Buy
2020-04-02 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-01-29 Downgrade Wolfe Research Outperform → Peer Perform
2020-01-22 Aggiornamento Wells Fargo Underweight → Equal Weight
2019-12-12 Aggiornamento JP Morgan Neutral → Overweight
2019-12-02 Iniziato Goldman Neutral
2019-10-25 Iniziato Cowen Outperform
2019-09-12 Iniziato Guggenheim Buy
2019-08-15 Aggiornamento TD Securities Hold → Buy
2019-07-19 Iniziato Wolfe Research Outperform
2019-06-11 Ripresa Barclays Overweight
2019-05-13 Aggiornamento JP Morgan Underweight → Neutral
2019-03-20 Iniziato SunTrust Buy
2019-01-02 Aggiornamento Piper Jaffray Neutral → Overweight
2018-11-05 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2018-09-13 Aggiornamento Piper Jaffray Underweight → Neutral
Mostra tutto

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

pulisher
08:54 AM

What analysts say about Bausch Health Companies Inc. stockFree Investment Timing Strategies - Jammu Links News

08:54 AM
pulisher
01:44 AM

What drives Bausch Health Companies Inc. stock priceRemarkable growth - Jammu Links News

01:44 AM
pulisher
Jul 18, 2025

Is Bausch Health Companies Inc. a good long term investmentPhenomenal returns - Jammu Links News

Jul 18, 2025
pulisher
Jul 17, 2025

Best Stock to Buy Right Now: Bausch Health vs Canopy Growth? - The Motley Fool Canada

Jul 17, 2025
pulisher
Jul 15, 2025

Bausch Health Faces Patent Drama And Policy Questions This Quarter - Finimize

Jul 15, 2025
pulisher
Jul 15, 2025

Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

In the Wake of Bausch Health Companies Inc.'s (NYSE:BHC) Latest US$196m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions - 富途牛牛

Jul 15, 2025
pulisher
Jul 15, 2025

In the wake of Bausch Health Companies Inc.'s (NYSE:BHC) latest US$196m market cap drop, institutional owners may be forced to take severe actions - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Amblyopia Market Growth Expected to See Next Level with Novartis - openPR.com

Jul 15, 2025
pulisher
Jul 12, 2025

Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel - Yahoo Finance

Jul 12, 2025
pulisher
Jul 11, 2025

Icahn Enterprises shares rise 5.72% intraday after Bausch Health appoints new Chief Accounting Officer. - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

Bausch Health's Strategic Leadership Shift: Steven Lee's Expertise Could Propel Valuation Growth Amid Transformation - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

First-Ever Triple-Combination Acne Treatment CABTREO Expands Access Across Canadian Health Programs - Stock Titan

Jul 10, 2025
pulisher
Jul 10, 2025

Bausch Health Names Steven Lee Chief Accounting Officer - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Bausch Health Appoints New Chief Accounting Officer - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Bausch Health Strengthens Finance Team: M&A Expert Steven Lee Takes Chief Accounting Officer Role - Stock Titan

Jul 10, 2025
pulisher
Jul 09, 2025

Groundbreaking Triple-Combination Acne Treatment Expands Access Across Canadian Healthcare System - Stock Titan

Jul 09, 2025
pulisher
Jul 09, 2025

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs - Yahoo Finance

Jul 09, 2025
pulisher
Jul 07, 2025

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence - standard-journal.com

Jul 07, 2025
pulisher
Jul 07, 2025

First FDA-Approved Drug Xifaxan Unveils Powerful Patient Stories in New Hepatic Encephalopathy Campaign - Stock Titan

Jul 07, 2025
pulisher
Jul 03, 2025

SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Jul 03, 2025
pulisher
Jul 03, 2025

Bausch Health Companies Reaches Analyst Target Price - Nasdaq

Jul 03, 2025
pulisher
Jul 03, 2025

August 22nd Options Now Available For Bausch Health Companies (BHC) - Nasdaq

Jul 03, 2025
pulisher
Jul 02, 2025

Stocks In Play: Bausch Health Companies - Barchart.com

Jul 02, 2025
pulisher
Jul 02, 2025

Bausch Health to Announce Second Quarter 2025 Results on July 30 - Corsicana Daily Sun

Jul 02, 2025
pulisher
Jul 01, 2025

Bausch + Lomb's Dry Eye Campaign: A Strategic Opportunity in Growing Eye Health Markets - AInvest

Jul 01, 2025
pulisher
Jun 29, 2025

BHC SEC FilingsBausch Health Companies Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 29, 2025
pulisher
Jun 26, 2025

Bausch + Lomb Brief: Closes Upsized 675 Million Euro Senior Secured Notes Offering and Partial Credit Agreement Refinancing - MarketScreener

Jun 26, 2025
pulisher
Jun 20, 2025

Fed. Circ. Revives MSN Challenge To Bausch IBS Drug Patent - Law360

Jun 20, 2025
pulisher
Jun 18, 2025

Bausch + Lomb Brief: Prices Upsized Senior Secured Notes Offering - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Bausch Health ticks higher following large director stock purchase - MSN

Jun 18, 2025
pulisher
Jun 17, 2025

John Paulson buying at Bausch Health Companies (BHC) - The Globe and Mail

Jun 17, 2025
pulisher
Jun 17, 2025

Bausch Health Companies: Insider Confidence Fuels Undervalued Stock's Turnaround Potential - AInvest

Jun 17, 2025
pulisher
Jun 16, 2025

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

Director buying at Bausch Health Companies (BHC) - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

Bausch Health: Repricing Potential Driven By Deleveraging (NYSE:BHC) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 15, 2025

Bausch Health Companies Inc. (TSE:BHC) Director John Paulson Acquires 754,134 Shares - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds - MSN

Jun 14, 2025
pulisher
Jun 14, 2025

LOOK: These 10 Stocks Just Stole The Show - Insider Monkey

Jun 14, 2025
pulisher
Jun 13, 2025

Bausch Health (BHC) Rises After Director's $15M Share Purchase - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Bausch Health Companies Stock Price, Quotes and Forecasts | NYSE:BHC - Benzinga

Jun 13, 2025
pulisher
Jun 13, 2025

Hedge Fund and Insider Trading News: Philippe Laffont, Warren Buffett, Bill Ackman, Farallon Capital, Bausch Health Companies Inc (BHC), MicroStrategy Inc (MSTR), and More - Insider Monkey

Jun 13, 2025
pulisher
Jun 12, 2025

Rising Demand in Traveler's Diarrhea MarketTop Developments, - openPR.com

Jun 12, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 11, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Benzodiazepine Drugs Market Trends, Growth Forecast, and Top - openPR.com

Jun 11, 2025
pulisher
Jun 10, 2025

Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Bausch + Lomb Brief: Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com

Jun 10, 2025
pulisher
Jun 06, 2025

Huntington's Disease Market Grows with Increased Genetic - openPR.com

Jun 06, 2025
pulisher
Jun 04, 2025

Reconstructive Surgery Market Trends, Size & Growth Forecast - openPR.com

Jun 04, 2025

Bausch Health Companies Inc Azioni (BHC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.18
price down icon 4.65%
$14.78
price down icon 1.20%
$8.88
price down icon 4.21%
drug_manufacturers_specialty_generic RDY
$14.48
price down icon 1.43%
$132.02
price down icon 1.56%
$292.01
price down icon 1.79%
Capitalizzazione:     |  Volume (24 ore):